Egis tied as the most popular employer for science students and young graduates and early-stage professionals, found a new study analysing the preferences of young employees and graduates in Hungary.

Our Polish branch, Egis Polska, has been present on the market for 25 years and has made a tangible change in the country’s medical reality. Egis Polska introduces innovative medicines, including biological therapies, acts as a respected partner for the medical community, and is recognized as a valued employer, regularly awarded for creating a quality work environment.

The pharmaceutical industry plays a key role in the Hungarian economy’s change of dimension.

To support the CSR activities of local companies, the Hungarian Business Responsibility founded its special awards, called CSR Hungary. This year, Egis was awarded in the ‘Inner CSR Solutions’ category that comes with a two-year trademark right.

PharmaBoardroom is a site for senior professionals, providing global news, trends and reports relating to the pharmaceutical industry.

Egis Pharmaceutical PLC’s Senior pharmaceutical sales rep participated very successfully at Medigames. Having won two gold medals, four silvers, and three bronze, pharmacist Dr. Judit Karagics contributed considerably to the 3rd place Hungary reached in the medal table. This excellent performance strengthens Egis’ reputation in the international target groups.

Egis Russia’s Buy for Good campaign that was carried out in 2018 won the award of ‘Best Social Projects in Russia’ in the category of medical and social projects.

Following the success of Egis Russia and Egis Polska, we are proud to announce that Egis Praha has also been recognized as Best Employer at Aon Hewitt’s Employee Engagement Survey.

The quality of life of millions depends on the availability of our medicines. Egis is one of the leading generic pharmaceutical companies in Central Easter Europe. We produce approximately 170 million boxes of drugs, 700 tonnes of active pharmaceutical ingredients, 5 billion tablets, capsules annually. Our products are available in 65 countries, and annually more than 30 million patients’ recovery depends on Egis Group’s continuous operation.

WHO has created a six-step protocol: by applying this method, we can remove the germs, viruses, and bacteria from the surface of our hands.

Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries.

Health means more than just the lack of illnesses.

As research and development are fundamental pillars of our strategy Egis is deeply committed to raise students’ interest in science and help the promising young minds develop their talents. That is why we have been supporting the annual ’Scientific and Innovation Talent Recruitment Contest for Youth’ for decades. This year, Egis’ prize went to undergraduate student Hunor Sebők.

The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer cooperation than before. Our common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.

Microsoft and HR Fest — the largest HR professional festival in Hungary — established a new professional award category within HR Best awards called ‘Future Proof Organizations’.

Egis and our consortia partners have won 2,332 billion HUF direct grant in the framework of the innovation tender GINOP-2.2.1-15-2016-00023 for the realisation of the above-mentioned project.

Egis Russia’s Buy for Good campaign that was carried out in 2018 won the award of ‘Best Social Projects in Russia’ in the category of medical and social projects.

In close cooperation with our employees, we're currently working on redesigning our protective clothing. Though the project is still in progress, our collaboration was already acknowledged: we were awarded the Healthy Workplaces Good Practice Award, so we can move on to the next round organized for EU countries.

Close to 300 Egis employees give blood on a regular basis at our Budapest sites. For our contribution, we received a certificate of merit from the Hungarian Red Cross.

Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life. Each and every employee is important and valuable to us.

In close cooperation with our employees, we're currently working on redesigning our protective clothing. Though the project is still in progress, our collaboration was already acknowledged: we were awarded the Healthy Workplaces Good Practice Award, so we can move on to the next round organized for EU countries.

With programs focusing on counseling and prevention, Egis was present on the Day of Vascular Diseases.

This March marks the official start of the Hungarian Nationwide Public Health Screening Program’s special campaign: the new initiative focuses on children’s health.

A Hungarian wildlife photographer, Bence Máté intends to shake up the public in order to protect nature. His spectacular nature photo exhibition series - organized in Budapest, then at the main square of another seven provincial towns – was opened by János Áder on 13 March. The outstanding project was supported by Egis.